UniProtKB AC (Name) | UniProtKB Section | Organism | Description | |
---|---|---|---|---|
O60239 (3BP5_HUMAN) | Swiss-Prot | Homo sapiens (Human) | SH3 domain-binding protein 5; SH3 domain-binding protein that preferentially associates with BTK; | |
Q8WXA8 (5HT3C_HUMAN) | Swiss-Prot | Homo sapiens (Human) | 5-hydroxytryptamine receptor 3C; Serotonin receptor 3C; | |
Q70Z44 (5HT3D_HUMAN) | Swiss-Prot | Homo sapiens (Human) | 5-hydroxytryptamine receptor 3D; Serotonin receptor 3D; | |
A5X5Y0 (5HT3E_HUMAN) | Swiss-Prot | Homo sapiens (Human) | 5-hydroxytryptamine receptor 3E; Serotonin receptor 3E; | |
Q9NRW3 (ABC3C_HUMAN) | Swiss-Prot | Homo sapiens (Human) | DNA dC->dU-editing enzyme APOBEC-3C; APOBEC1-like; Phorbolin I; | |
Q6UXT9 (ABH15_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Protein ABHD15; Alpha/beta hydrolase domain-containing protein 15; | |
Q9H3Z7 (ABHGB_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Protein ABHD16B; Alpha/beta hydrolase domain-containing protein 16B; | |
Q9NX38 (ABITM_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Protein Abitram; Actin-binding transcription modulator; Protein Simiate; | |
Q96AP0 (ACD_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Adrenocortical dysplasia protein homolog; POT1 and TIN2-interacting protein; | |
Q9GZZ6 (ACH10_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Neuronal acetylcholine receptor subunit alpha-10; Nicotinic acetylcholine receptor subunit alpha-10; | |
P30532 (ACHA5_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Neuronal acetylcholine receptor subunit alpha-5; | |
Q05901 (ACHB3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Neuronal acetylcholine receptor subunit beta-3; | |
P11229 (ACM1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Muscarinic acetylcholine receptor M1; | |
P08172 (ACM2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Muscarinic acetylcholine receptor M2; | |
P08913 (ADA2A_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Alpha-2A adrenergic receptor; Alpha-2 adrenergic receptor subtype C10; Alpha-2A adrenoreceptor; | |
Q7Z6V5 (ADAT2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | tRNA-specific adenosine deaminase 2; Deaminase domain-containing protein 1; tRNA-specific adenosine-34 deaminase subunit ADAT2; | |
O15204 (ADEC1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | ADAM DEC1; A disintegrin and metalloproteinase domain-like protein decysin-1; | |
P35318 (ADML_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Pro-adrenomedullin; Adrenomedullin; AM; Proadrenomedullin N-20 terminal peptide; ProAM N-terminal 20 peptide; PAMP; ProAM-N20; | |
Q9GZN8 (ADSSP_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Adipose-secreted signaling protein; | |
Q5BKT4 (AG10A_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase; Alpha-1,2-glucosyltransferase ALG10-A; Alpha-2-glucosyltransferase ALG10-A; Asparagine-linked glycosylation protein 10 homolog A; | |
Q5I7T1 (AG10B_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Putative Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase; Alpha-1,2-glucosyltransferase ALG10-A; Alpha-2-glucosyltransferase ALG10-B; Asparagine-linked glycosylation protein 10 homolog B; Potassium channel regulator 1; | |
O95994 (AGR2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Anterior gradient protein 2 homolog; HPC8; Secreted cement gland protein XAG-2 homolog; | |
Q86SQ3 (AGRE4_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Putative adhesion G protein-coupled receptor E4P; EGF-like module receptor 4; EGF-like module-containing mucin-like hormone receptor-like 4; G-protein coupled receptor 127; G-protein coupled receptor PGR16; | |
P43353 (AL3B1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Aldehyde dehydrogenase family 3 member B1; Aldehyde dehydrogenase 7; | |
Q9NP70 (AMBN_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Ameloblastin; | |
Q9BXJ7 (AMNLS_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Protein amnionless; Soluble protein amnionless; | |
Q96K21 (ANCHR_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Abscission/NoCut checkpoint regulator; MLL partner containing FYVE domain; Zinc finger FYVE domain-containing protein 19; | |
Q9Y5C1 (ANGL3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Angiopoietin-related protein 3; Angiopoietin-5; Angiopoietin-like protein 3; ANGPTL3(17-221); ANGPTL3(17-224); | |
Q8NI99 (ANGL6_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Angiopoietin-related protein 6; Angiopoietin-like protein 6; Angiopoietin-related growth factor; Angiopoietin-related protein 5; | |
Q5VYY1 (ANR22_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Ankyrin repeat domain-containing protein 22; | |
Q53RE8 (ANR39_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Ankyrin repeat domain-containing protein 39; | |
Q92481 (AP2B_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Transcription factor AP-2-beta; Activating enhancer-binding protein 2-beta; | |
Q92754 (AP2C_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Transcription factor AP-2 gamma; Activating enhancer-binding protein 2 gamma; Transcription factor ERF-1; | |
O00189 (AP4M1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | AP-4 complex subunit mu-1; AP-4 adaptor complex mu subunit; Adaptor-related protein complex 4 subunit mu-1; Mu subunit of AP-4; Mu-adaptin-related protein 2; Mu4-adaptin; | |
Q9UM13 (APC10_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Anaphase-promoting complex subunit 10; Cyclosome subunit 10; | |
P05090 (APOD_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Apolipoprotein D; | |
P61204 (ARF3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | ADP-ribosylation factor 3; | |
P18085 (ARF4_HUMAN) | Swiss-Prot | Homo sapiens (Human) | ADP-ribosylation factor 4; | |
P84085 (ARF5_HUMAN) | Swiss-Prot | Homo sapiens (Human) | ADP-ribosylation factor 5; | |
P62330 (ARF6_HUMAN) | Swiss-Prot | Homo sapiens (Human) | ADP-ribosylation factor 6; | |
Q8IVW1 (ARL17_HUMAN) | Swiss-Prot | Homo sapiens (Human) | ADP-ribosylation factor-like protein 17; ADP-ribosylation factor 7 variant; | |
P40616 (ARL1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | ADP-ribosylation factor-like protein 1; | |
P36404 (ARL2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | ADP-ribosylation factor-like protein 2; | |
P36405 (ARL3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | ADP-ribosylation factor-like protein 3; | |
Q9Y689 (ARL5A_HUMAN) | Swiss-Prot | Homo sapiens (Human) | ADP-ribosylation factor-like protein 5A; | |
Q96KC2 (ARL5B_HUMAN) | Swiss-Prot | Homo sapiens (Human) | ADP-ribosylation factor-like protein 5B; ADP-ribosylation factor-like protein 8; | |
A6NH57 (ARL5C_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Putative ADP-ribosylation factor-like protein 5C; ADP-ribosylation factor-like protein 12; | |
Q9H0F7 (ARL6_HUMAN) | Swiss-Prot | Homo sapiens (Human) | ADP-ribosylation factor-like protein 6; Bardet-Biedl syndrome 3 protein; | |
Q96BM9 (ARL8A_HUMAN) | Swiss-Prot | Homo sapiens (Human) | ADP-ribosylation factor-like protein 8A; ADP-ribosylation factor-like protein 10B; Novel small G protein indispensable for equal chromosome segregation 2; | |
Q9NVJ2 (ARL8B_HUMAN) | Swiss-Prot | Homo sapiens (Human) | ADP-ribosylation factor-like protein 8B; ADP-ribosylation factor-like protein 10C; Novel small G protein indispensable for equal chromosome segregation 1; |
Homo sapiens (Latin: "wise man") is the species name for humans. Believed to have originated in Africa, Homo sapiens is the only surviving member of the Homo genus.
The first complete draft of the human genome was completed in 2001 with an estimated cost of $300million. With the advances in DNA sequencing methods, this price has dropped dramatically down to almost $1000 per genome. By combining the individual genome information with other data, such as protein structure models, personalised medicine becomes viable.
From left to right: i) The number of proteins in the reference proteome of Homo sapiens, ii) the number of unique protein sequences for which at least one model is available, iii) the total number of models and iv) a coverage bar plot is shown.
The bar plot shows the coverage for every protein in the reference proteome of Homo sapiens for which there is at least one model. Different colours (dark green to red boxes) represent the coverage of the targets. Targets with high coverage are represented in dark green (more than 80% of the target's length is covered by models), whereas low coverage is shown in red. The size of each box is proportional to the number of target sequences with a given coverage.
For information on the latest proteome for Homo sapiens, please visit Proteome.
You can easily download the latest protein sequences for Homo sapiens proteome here. Please note this download is for the current UniProtKB release, which may be different to release 2024_02 that was used for the most up to date SWISS-MODEL Repository.
Proteins in proteome | Sequences modelled | Models |
20,598 | 17,358 | 42,928 |
Detailed coverage numbers are obtained by hovering the mouse over one of the boxes.
The plot shows the evolution over years (x-axis) of the fraction of Homo sapiens reference proteome residues (y-axis) for which structural information is available. Different colors (light blue to dark blue) in the plot represent the quality of the sequence alignment between the reference proteome sequences (targets) and the sequences of the proteins in the structure database (templates). Alignments with low sequence identity are displayed in light blue, whereas alignments with high sequence identity are depicted in dark blue. The SWISS-MODEL Template Library is used as database of templates. Only target-template alignments found by HHblits and only residues with atom coordinates are considered.
This chart shows the percentage of residues in the Homo sapiens proteome which are covered by experimental structures and the enhancement of coverage by homology modelling by the SWISS-MODEL pipeline. Experimental residue coverage is determined using SIFTS mapping. For residues which are not covered by experimental structures (including where there are no atom records in SIFTS mapping) the model coverage bars are coloured by QMEANDisCo local quality score.
Many proteins form oligomeric structures either by self-assembly (homo-oligomeric) or by assembly with other proteins (hetero-oligomeric) to accomplish their function. In SWISS-MODEL Repository, the quaternary structure annotation of the template is used to model the target sequence in its oligomeric form. Currently our method is limited to the modelling of homo-oligomeric assemblies. The oligomeric state of the template is only considered if the interface is conserved.
Single Chain | 2-mer | 3-mer | 4-mer | 5-mer | 6-mer | 7-mer | 8-mer | 9-mer | 10-mer | 11-mer | 12-mer | 13-mer | 14-mer | 16-mer | 18-mer | 20-mer | 21-mer | 22-mer | 24-mer | 25-mer | 26-mer | 32-mer | 34-mer | 36-mer | 39-mer | 40-mer | 44-mer | 46-mer | 48-mer | 55-mer | 56-mer | 60-mer | 62-mer |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
38,419 | 3,200 | 302 | 594 | 64 | 118 | 14 | 57 | 3 | 29 | 11 | 38 | 1 | 3 | 22 | 4 | 2 | 1 | 1 | 16 | 1 | 1 | 1 | 1 | 1 | 1 | 5 | 1 | 1 | 4 | 2 | 4 | 4 | 2 |